Skip to content

ClearPoint System

by Clearpoint Neuro, Inc.

510(k) K222519

ClearPoint System is a medical device (FDA Class II; FDA product code HAW, Neurological Stereotaxic Instrument) made by Clearpoint Neuro, Inc., cleared under FDA 510(k) K222519 on 16 Sep 2022, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK222519 Date16 Sep 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
19 Aug 2022
FDA decision
16 Sep 2022 (Substantially Equivalent)
FDA review time
28 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K222519 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
HAW
Device class
Class II
Regulation
21 CFR Part 882.4560
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code HAW (Neurological Stereotaxic Instrument).

Other devices from Clearpoint Neuro, Inc.

See all devices from Clearpoint Neuro, Inc. →